The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Dealing with Mortality After Most cancers, and Selecting to Stay Totally

Just lately, I noticed a meme in a most cancers assist group that mentioned “All of us have expiration dates. Most cancers...

Trodelvy in Metastatic Triple-Destructive Breast Most cancers Supported by Part 3 Trial

Therapy with Trodelvy (Sacituzumab govitecan) diminished the danger for illness development or demise by 38% versus chemotherapy amongst sufferers with beforehand untreated,...

Imfinzi With Chemo Produces Inconclusive Outcomes in Part 3 Mesothelioma Examine

Within the section 3 DREAM3R research, first-line therapy with Imfinzi (durvalumab) plus chemotherapy demonstrated constant enhancements in total survival, progression-free survival, and...

Supplemental Xtandi Does Not Enhance Metastasis-Free Survival in Excessive-Threat Prostate Most cancers

The addition of two years of Xtandi (enzalutamide) to plain androgen deprivation remedy (ADT) and high-dose radiation remedy didn't considerably enhance metastasis-free...

Imfinzi Combo Improves Development Free Survival in Ovarian Most cancers

Platinum-based chemotherapy plus Imfinzi (durvalumab), Avastin (bevacizumab), and Lynparza (olaparib) confirmed a statistically vital and clinically significant enchancment in median progression-free survival...

Hot Topics